Skip to main content
Top
Published in:

01-06-2023 | Spinocerebellar Ataxia | Original Article

Diagnostic Delay of Hereditary Ataxias in Brazil: the Case of Machado-Joseph Disease

Authors: Jordânia dos Santos Pinheiro, Lucas Schenatto Sena, Karina Carvalho Donis, Gabriel Vasata Furtado, Maria Luiza Saraiva-Pereira, Laura Bannach Jardim

Published in: The Cerebellum | Issue 3/2023

Login to get access

Abstract

Background

Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a rare disease with diagnosis offered by the Unified Health System in Brazil. Our aim was to investigate the diagnostic delay in an interval of 23 years in a public university hospital, and some potentially determining factors.

Methods

A retrospective review of the medical records of subjects identified at our institution between 1999 and 2017 was carried out, including residents of Rio Grande do Sul. The diagnostic delay was equivalent to the difference between age at onset of symptoms and age at molecular diagnosis. Calendar years, educational level, sex, distance between the household and the clinics, age and being the index case were studied as modifying factors.

Results

SCA3/MJD had a median diagnostic delay of 5 years. Index cases had delays of 6 versus 4 years (p<0.001) for subsequent family members. Delay correlated with age (rho=0.346, p<0.001), but not with age at disease onset (rho=0.005, p=0.91). No change was observed with the level of education of individuals or with the distance between household and hospital from 1999 to 2017.

Discussion

The diagnostic delay of SCA3/MJD is high in our region, where its occurrence has been reported for years. Failure to change the delay over the years suggests ineffective dissemination to the population, but a smaller lag among younger people can portray the effect of digital inclusion.
Literature
1.
go back to reference Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y, et al. The gene for Machado–Joseph disease maps to human chromosome 14q. Nat Genet. 1993;4:300–4.CrossRefPubMed Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y, et al. The gene for Machado–Joseph disease maps to human chromosome 14q. Nat Genet. 1993;4:300–4.CrossRefPubMed
2.
go back to reference Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32. Nature genetics. 1994;18:221–8.CrossRef Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32. Nature genetics. 1994;18:221–8.CrossRef
3.
go back to reference Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.CrossRefPubMed Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.CrossRefPubMed
4.
go back to reference Sequeiros J, Martins S, Silveira I. Epidemiology and population genetics of degenerative ataxias. Handbook of clinical neurology. pp 227–25. 2012. Sequeiros J, Martins S, Silveira I. Epidemiology and population genetics of degenerative ataxias. Handbook of clinical neurology. pp 227–25. 2012.
5.
go back to reference Rodríguez-Labrada R, Martins AC, Magaña JJ, Vazquez-Mojena Y, Medrano-Montero J, Fernandez-Ruíz J, et al. Founder effects of spinocerebellar ataxias in the American continents and the Caribbean. The Cerebellum. 2020;19:446–58.CrossRefPubMed Rodríguez-Labrada R, Martins AC, Magaña JJ, Vazquez-Mojena Y, Medrano-Montero J, Fernandez-Ruíz J, et al. Founder effects of spinocerebellar ataxias in the American continents and the Caribbean. The Cerebellum. 2020;19:446–58.CrossRefPubMed
6.
go back to reference Saute JAM, Jardim LB. Machado Joseph disease: clinical and genetic aspects, and current treatment. Expert Opinion on Orphan Drugs. 2015;3:517–35.CrossRef Saute JAM, Jardim LB. Machado Joseph disease: clinical and genetic aspects, and current treatment. Expert Opinion on Orphan Drugs. 2015;3:517–35.CrossRef
12.
go back to reference Paulson H, Shakkottai V. Spinocerebellar Ataxia Type 3. 1998 Oct 10 [updated 2020 Jun 4]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. Paulson H, Shakkottai V. Spinocerebellar Ataxia Type 3. 1998 Oct 10 [updated 2020 Jun 4]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022.
13.
go back to reference Abela L, Plecko B, Palla A, Burda P, Nuoffer JM, Ballhausen D, Rohrbach M. Early co-occurrence of a neurologic-psychiatric disease pattern in Niemann-Pick type C disease: a retrospective Swiss cohort study. Orphanet J Rare Dis. 2014;26(9):176.CrossRef Abela L, Plecko B, Palla A, Burda P, Nuoffer JM, Ballhausen D, Rohrbach M. Early co-occurrence of a neurologic-psychiatric disease pattern in Niemann-Pick type C disease: a retrospective Swiss cohort study. Orphanet J Rare Dis. 2014;26(9):176.CrossRef
14.
go back to reference Nie S, Chen G, Cao X, Zhang Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014;26(9):179.CrossRef Nie S, Chen G, Cao X, Zhang Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014;26(9):179.CrossRef
15.
go back to reference Devaney R, Pasalodos S, Suri M, Bush A, Bhatt JM. Ataxia telangiectasia: presentation and diagnostic delay. Arch Dis Child. 2017;102:328–30.CrossRefPubMed Devaney R, Pasalodos S, Suri M, Bush A, Bhatt JM. Ataxia telangiectasia: presentation and diagnostic delay. Arch Dis Child. 2017;102:328–30.CrossRefPubMed
16.
go back to reference Schon K, van Os NJH, Oscroft N, Baxendale H, Scoffings D, Ray J, Suri M, Whitehouse WP, Mehta PR, Everett N, Bottolo L, van de Warrenburg BP, Byrd PJ, Weemaes C, Willemsen MA, Tischkowitz M, Taylor AM, Hensiek AE. Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia. Ann Neurol. 2019;85:170–80.PubMedPubMedCentral Schon K, van Os NJH, Oscroft N, Baxendale H, Scoffings D, Ray J, Suri M, Whitehouse WP, Mehta PR, Everett N, Bottolo L, van de Warrenburg BP, Byrd PJ, Weemaes C, Willemsen MA, Tischkowitz M, Taylor AM, Hensiek AE. Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia. Ann Neurol. 2019;85:170–80.PubMedPubMedCentral
17.
go back to reference van Os NJH, Hensiek A, van Gaalen J, Taylor AMR, van Deuren M, Weemaes CMR, Willemsen MAAP, van de Warrenburg BPC. Trajectories of motor abnormalities in milder phenotypes of ataxia telangiectasia. Neurology. 2019;92:e19–29.CrossRefPubMed van Os NJH, Hensiek A, van Gaalen J, Taylor AMR, van Deuren M, Weemaes CMR, Willemsen MAAP, van de Warrenburg BPC. Trajectories of motor abnormalities in milder phenotypes of ataxia telangiectasia. Neurology. 2019;92:e19–29.CrossRefPubMed
18.
go back to reference Indelicato E, Nachbauer W, Eigentler A, Amprosi M, Matteucci Gothe R, Giunti P, Mariotti C, Arpa J, Durr A, Klopstock T, Schöls L, Giordano I, Bürk K, Pandolfo M, Didszdun C, Schulz JB, Boesch S. EFACTS (European Friedreich’s Ataxia Consortium for Translational Studies). Onset features and time to diagnosis in Friedreich’s Ataxia. Orphanet J Rare Dis. 2020;15:198.CrossRefPubMedPubMedCentral Indelicato E, Nachbauer W, Eigentler A, Amprosi M, Matteucci Gothe R, Giunti P, Mariotti C, Arpa J, Durr A, Klopstock T, Schöls L, Giordano I, Bürk K, Pandolfo M, Didszdun C, Schulz JB, Boesch S. EFACTS (European Friedreich’s Ataxia Consortium for Translational Studies). Onset features and time to diagnosis in Friedreich’s Ataxia. Orphanet J Rare Dis. 2020;15:198.CrossRefPubMedPubMedCentral
19.
go back to reference Souza GN, Kersting N, Krum-Santos AC, Santos ASP, Furtado GV, Pacheco D, et al. Spinocerebellar ataxia type 3/Machado–Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions. Clinical genetics. 2016;90:134–40.CrossRefPubMed Souza GN, Kersting N, Krum-Santos AC, Santos ASP, Furtado GV, Pacheco D, et al. Spinocerebellar ataxia type 3/Machado–Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions. Clinical genetics. 2016;90:134–40.CrossRefPubMed
20.
go back to reference Cecchin CR, Pires AP, Rieder CR, Monte TL, Silveira I, Carvalho T, et al. Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives. Public Health Genomics. 2007;10:19–26.CrossRef Cecchin CR, Pires AP, Rieder CR, Monte TL, Silveira I, Carvalho T, et al. Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives. Public Health Genomics. 2007;10:19–26.CrossRef
21.
go back to reference Saute JAM, da Silva ACF, Donis KC, Vedolin L, Saraiva-Pereira ML, Jardim LB. Depressive mood is associated with ataxic and non-ataxic neurological dysfunction in SCA3 patients. The Cerebellum. 2010;9:603–5.CrossRefPubMed Saute JAM, da Silva ACF, Donis KC, Vedolin L, Saraiva-Pereira ML, Jardim LB. Depressive mood is associated with ataxic and non-ataxic neurological dysfunction in SCA3 patients. The Cerebellum. 2010;9:603–5.CrossRefPubMed
22.
go back to reference Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, et al. Depression comorbidity in spinocerebellar ataxia. Movement disorders. 2011;26:870–6.CrossRefPubMed Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, et al. Depression comorbidity in spinocerebellar ataxia. Movement disorders. 2011;26:870–6.CrossRefPubMed
23.
go back to reference Braga-Neto P, Pedroso JL, Alessi H, Dutra LA, Felício AC, Minett T, et al. Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features. The Cerebellum. 2012;11:549–56.CrossRefPubMed Braga-Neto P, Pedroso JL, Alessi H, Dutra LA, Felício AC, Minett T, et al. Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features. The Cerebellum. 2012;11:549–56.CrossRefPubMed
24.
go back to reference Silva UCA, Marques W, Lourenço CM, Hallak JEC, Osório FL. Psychiatric disorders, spinocerebellar ataxia type 3 and CAG expansion. Journal of neurology. 2015;262:1777–9.CrossRefPubMed Silva UCA, Marques W, Lourenço CM, Hallak JEC, Osório FL. Psychiatric disorders, spinocerebellar ataxia type 3 and CAG expansion. Journal of neurology. 2015;262:1777–9.CrossRefPubMed
25.
go back to reference Yap KH, Kessels RP, Azmin S, van de Warrenburg B, Ibrahim NM. Neurocognitive changes in spinocerebellar ataxia type 3: a systematic review with a narrative design. Cerebellum. 2021 Jul 7. doi: 10.1007/s12311-021-01282-3. Epub ahead of print. Yap KH, Kessels RP, Azmin S, van de Warrenburg B, Ibrahim NM. Neurocognitive changes in spinocerebellar ataxia type 3: a systematic review with a narrative design. Cerebellum. 2021 Jul 7. doi: 10.1007/s12311-021-01282-3. Epub ahead of print.
26.
go back to reference Dubovsky, S. L., Davies, R., & Dubovsky, A. N. (2003). Mood disorders. In R. E. Hales & S. C. Yudofsky (Eds.), The American Psychiatric Publishing textbook of clinical psychiatry (pp. 439–542). American Psychiatric Publishing, Inc. Dubovsky, S. L., Davies, R., & Dubovsky, A. N. (2003). Mood disorders. In R. E. Hales & S. C. Yudofsky (Eds.), The American Psychiatric Publishing textbook of clinical psychiatry (pp. 439–542). American Psychiatric Publishing, Inc.
27.
go back to reference Fernandez E, Turk DC. The scope and significance of anger in the experience of chronic pain. Pain. 1995;61:165–75.CrossRefPubMed Fernandez E, Turk DC. The scope and significance of anger in the experience of chronic pain. Pain. 1995;61:165–75.CrossRefPubMed
28.
go back to reference Radin M, Foddai SG, Barinotti A, Cecchi I, Rubin E, Sciascia S, et al. Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. Orphanet Journal of Rare Diseases. 2021;16:1–5.CrossRef Radin M, Foddai SG, Barinotti A, Cecchi I, Rubin E, Sciascia S, et al. Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. Orphanet Journal of Rare Diseases. 2021;16:1–5.CrossRef
29.
go back to reference Guo X, Wang K, Yu S, Gao L, Wang Z, Zhu H, et al. Patient characteristics, diagnostic delays, treatment patterns, treatment outcomes, comorbidities, and treatment costs of acromegaly in China: a nationwide study. Frontiers in Endocrinology. 2020;11:610519.CrossRefPubMedPubMedCentral Guo X, Wang K, Yu S, Gao L, Wang Z, Zhu H, et al. Patient characteristics, diagnostic delays, treatment patterns, treatment outcomes, comorbidities, and treatment costs of acromegaly in China: a nationwide study. Frontiers in Endocrinology. 2020;11:610519.CrossRefPubMedPubMedCentral
30.
go back to reference Gainotti S, Mascalzoni D, Bros-Facer V, Petrini C, Floridia G, Roos M, et al. Meeting patients’ right to the correct diagnosis: ongoing international initiatives on undiagnosed rare diseases and ethical and social issues. International journal of environmental research and public health. 2018;15:2072.CrossRefPubMedPubMedCentral Gainotti S, Mascalzoni D, Bros-Facer V, Petrini C, Floridia G, Roos M, et al. Meeting patients’ right to the correct diagnosis: ongoing international initiatives on undiagnosed rare diseases and ethical and social issues. International journal of environmental research and public health. 2018;15:2072.CrossRefPubMedPubMedCentral
31.
go back to reference Zielonka M, Garbade SF, Kölker S, Hoffmann GF, Ries M. Ultra-orphan lysosomal storage diseases: a cross-sectional quantitative analysis of the natural history of alpha-mannosidosis. Journal of inherited metabolic disease. 2019;42:975–83.CrossRefPubMed Zielonka M, Garbade SF, Kölker S, Hoffmann GF, Ries M. Ultra-orphan lysosomal storage diseases: a cross-sectional quantitative analysis of the natural history of alpha-mannosidosis. Journal of inherited metabolic disease. 2019;42:975–83.CrossRefPubMed
34.
go back to reference Vieira T, Schwartz I, Muñoz V, Pinto L, Steiner C, Ribeiro M, Boy R, Ferraz V, de Paula A, Kim C, Acosta A, Giugliani R. Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis? Am J Med Genet A. 2008;146A:1741–7.CrossRefPubMed Vieira T, Schwartz I, Muñoz V, Pinto L, Steiner C, Ribeiro M, Boy R, Ferraz V, de Paula A, Kim C, Acosta A, Giugliani R. Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis? Am J Med Genet A. 2008;146A:1741–7.CrossRefPubMed
Metadata
Title
Diagnostic Delay of Hereditary Ataxias in Brazil: the Case of Machado-Joseph Disease
Authors
Jordânia dos Santos Pinheiro
Lucas Schenatto Sena
Karina Carvalho Donis
Gabriel Vasata Furtado
Maria Luiza Saraiva-Pereira
Laura Bannach Jardim
Publication date
01-06-2023
Publisher
Springer US
Published in
The Cerebellum / Issue 3/2023
Print ISSN: 1473-4222
Electronic ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-022-01404-5

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more